Biotech Holdings LtdShs Aktie
WKN DE: 925970 / ISIN: CA0909381018
04.08.2025 13:15:00
|
This Biotech Stock Could Soar on Upcoming Clinical Data
While most investors pile into Eli Lilly (NYSE: LLY) or flee from struggling Novo Nordisk (NYSE: NVO), they're missing a compelling opportunity in the clinical-stage space. Novo recently lost nearly $70 billion in market cap after cutting 2025 guidance and warning of slowing Wegovy momentum, while the broader biotech industry's recent reawakening has created pockets of value among companies with differentiated approaches to weight management.Viking Therapeutics (NASDAQ: VKTX) represents exactly this type of overlooked opportunity, trading at a valuation of just $3.7 billion as of Aug. 1, despite owning one of the most strategically valuable obesity platforms in development. Here's what investors need to know right now.Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!